2000, Autism Research Institute, San Diego Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, Schopler E: Autism diagnostic observation schedule: a standardized observation of communicative and social behavior
The use of GLP-1RA is a new therapeutic strategy that addresses both metabolic and cognitive/neuropsychiatric aspects, which is fundamentally important for the treatment of comorbid diseases
The difference is receptor selectivity
Its a key player in your bodys energy production, which is why you might feel sluggish when your levels are low
Key Takeaways No dose equivalence: There is no validated dose equivalence between semaglutide and tirzepatide
Coverage of these diabetes and weight loss medications is shifting in some interesting ways